Bank of Montreal’s Loncar China BioPharma ETF CHNA Stock Holding History

Bank of Montreal’s Portfolio CHNA Stock Details CHNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-2,000	Closed	-$45K	–	4893
2020 Q1	$45K	Buy	+2,000	New	+$49.4K	﹤0.01%	2936

Other funds holding CHNA

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Bank of Montreal's CHNA Position: Q2 2020 in Review

Bank of Montreal sold out of Loncar China BioPharma ETF (CHNA) in Q2 2020, closing a stake of 2,000 shares — an estimated $45K sold.

Bank of Montreal first reported a position in CHNA in Q1 2020 and held it in 1 quarter. The position peaked at $45K in Q1 2020. 3 funds tracked by Wall St. Rank hold CHNA as of Q2 2020.

Bank of Montreal reported no remaining Loncar China BioPharma ETF position as of Q2 2020 after selling out during the quarter.
Bank of Montreal sold 2,000 Loncar China BioPharma ETF shares in Q2 2020, an estimated $45K.
Bank of Montreal first reported a position in Loncar China BioPharma ETF in Q1 2020 and held it in 1 quarter.
Bank of Montreal's Loncar China BioPharma ETF position peaked at $45K in Q1 2020.
3 funds tracked by Wall St. Rank held Loncar China BioPharma ETF as of Q2 2020.

Based on Bank of Montreal's 13F filing for Q2 2020, filed 12 Aug 2020.